| Initiation of acute graft-versus-host disease by angiogenesis K Riesner, Y Shi, A Jacobi, M Kräter, M Kalupa, A McGearey, S Mertlitz, ... Blood, The Journal of the American Society of Hematology 129 (14), 2021-2032, 2017 | 70 | 2017 |
| Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19: a randomized clinical trial CM Denkinger, M Janssen, U Schäkel, J Gall, A Leo, P Stelmach, ... Nature Cancer 4 (1), 96-107, 2023 | 49 | 2023 |
| Endothelial damage and dysfunction in acute graft-versus-host disease S Cordes, Z Mokhtari, M Bartosova, S Mertlitz, K Riesner, Y Shi, ... Haematologica 106 (8), 2147, 2021 | 29 | 2021 |
| Adaptive T-cell immunity controls senescence-prone MyD88-or CARD11-mutant B-cell lymphomas M Reimann, J Schrezenmeier, P Richter-Pechanska, A Dolnik, TP Hick, ... Blood, The Journal of the American Society of Hematology 137 (20), 2785-2799, 2021 | 29 | 2021 |
| Pharmacokinetics of Daclatasvir, Sofosbuvir, and GS-331007 in a Prospective Cohort of Hepatitis C Virus–Positive Kidney Transplant Recipients E Schrezenmeier, F Hoffmann, C Jaeger, J Schrezenmeier, J Lisec, ... Therapeutic drug monitoring 41 (1), 53-58, 2019 | 10 | 2019 |
| A randomized controlled clinical trial demonstrates that plasma from convalescent and vaccinated donors improves outcome of COVID-19 in patients with hematological disease … C Müller-Tidow, M Janssen, U Schäkel, J Gall, A Leo, P Stelmach, ... HemaSphere, 371-372, 2022 | 5 | 2022 |
| AML with complex karyotype: extreme genomic complexity revealed by combined long-read sequencing and Hi-C technology MK Klever, E Sträng, S Hetzel, J Jungnitsch, A Dolnik, R Schöpflin, ... Blood Advances 7 (21), 6520-6531, 2023 | 3 | 2023 |
| Integration of Hi-C and Nanopore Sequencing for Structural Variant Analysis in AML with a Complex Karyotype:(Chromothripsis) ² MK Klever, E Sträng, J Jungnitsch, US Melo, S Hetzel, A Dolnik, ... Blood 136, 28, 2020 | 3 | 2020 |
| Pharmakokinetics of daclatasvir, sofosbuvir and GS-331007 in a prospective cohort of HCV positive kidney transplant recipients E Schrezenmeier, P Galander, F Hoffmann, C Jaeger, J Lisec, ... AMERICAN JOURNAL OF TRANSPLANTATION 17, 508-509, 2017 | 1 | 2017 |
| Initiation of Acute Graft-Versus-Host Disease By Angiogenesis K Riesner, Y Shi, A Jacobi, M Kraeter, M Kalupa, A McGearey, S Mertlitz, ... Blood, The Journal of the American Society of Hematology 128 (22), 4533-4533, 2016 | 1 | 2016 |
| Modeling the CNS Tropism of Diffuse Large B-Cell Lymphomas in Vivo M Reimann, S Masswig, K Schleich, A Herrmann, P Lohneis, ... Blood, The Journal of the American Society of Hematology 126 (23), 576-576, 2015 | 1 | 2015 |
| 1142. Plasma with high titers of anti-SARS-Cov2 antibodies improves outcome of COVID-19 in patients with hematological malignancy and cancer in a randomized controlled trial CM Denkinger, M Janssen, U Schäkel, J Gall, A Leo, P Stelmach, ... Open Forum Infectious Diseases 9 (Supplement_2), ofac492. 980, 2022 | | 2022 |
| Rapid and Reproducible Karyotyping with Nanopore Sequencing in AML Patients M Heuser, N Damrah, R Gabdoulline, CK Lai, E Sträng, M Salim, ... Blood 140 (Supplement 1), 6070-6072, 2022 | | 2022 |
| Therapy-Related AML: Clinical/Biological Features and Long-Term Outcome in a Cohort of 1133 Adult AML Patients S Gross, J Ihlow, L Busack, K Adamiak, JF Schrezenmeier, J Jesse, ... Blood 140 (Supplement 1), 1291-1292, 2022 | | 2022 |
| P456: A LONG READ SEQUENCING AND CRISPR-CAS9 BASED APPROACH FOR RAPID COPY-NUMBER ALTERATION AND STRUCTURAL VARIATION DETECTION IN HEMATOLOGIC MALIGNANCIES J Schrezenmeier, JE Straeng, O Blau, A Elashy, A Lazarides, ... HemaSphere 6, 356-357, 2022 | | 2022 |
| S282: A RANDOMIZED CONTROLLED CLINICAL TRIAL DEMONSTRATES THAT PLASMA FROM CONVALESCENT AND VACCINATED DONORS IMPROVES OUTCOME OF COVID-19 IN PATIENTS WITH HEMATOLOGICAL … C Müller-Tidow, M Janssen, U Schäkel, J Gall, A Leo, P Stelmach, ... HemaSphere 6, 183-184, 2022 | | 2022 |
| Plasma with high titers of anti-SARS-Cov2 antibodies improves outcome of COVID-19 in patients with hematological malignancy and cancer in a randomized controlled trial CM Denkinger, M Janssen, U Schkel, J Gall, A Leo, P Stelmach, ... Open Forum Infectious Diseases, S488-S489, 2022 | | 2022 |
| Protection of the endothelium during steroid-refractory GVHD S Cordes, Z Mokhtarias, M Bartosova, K Riesner, S Mertlitz, ... BONE MARROW TRANSPLANTATION 54, 89-90, 2019 | | 2019 |
| Functional genomic investigation of the human aggressive lymphoma derived genetic lesions MYD88L265P, NFKBIZ, CARD11L244P, CD79BY196H and PD-L1 in a murine Eµ-myc lymphoma model JF Schrezenmeier | | 2019 |
| Genomic profiling in acute myeloid leukemia with complex karyotype A Dolnik, JE Straeng, C Lai, JF Schrezenmeier, A Maluck, FG Ruecker, ... ONCOLOGY RESEARCH AND TREATMENT 42, 168-169, 2019 | | 2019 |
